Concepedia

Benedikte Hasselbalch

BH

7

Publications

533

Citations

7

H-Index

2008

Active since

Affiliations

Copenhagen University Hospital(Current)

Rigshospitalet

University of Copenhagen

Benedikte Hasselbalch is an author at Copenhagen University Hospital specializing in cancer therapeutics, tumor microenvironment, and tumor biology.

ORCID

Top concepts

Publications per year

2008–2022

7

Publications

7

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial

Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen et al. · Neuro-Oncology · 2010 · 227 citations · Full text

Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours

Hans Skovgaard Poulsen, Kirsten Grunnet, Morten Mau‐Sørensen et al. · Acta Oncologica · 2008 · 101 citations · Full text

Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme.

Ulrik Lassen, Morten Mau‐Sørensen, Tine Bernhardtsen Gaziel et al. · PubMed · 2013 · 96 citations

Prospective evaluation of angiogenic, hypoxic and EGFR‐related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan

Benedikte Hasselbalch, Jesper Grau Eriksen, Helle Broholm et al. · Apmis · 2010 · 43 citations

, , +17

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution

Armita Armina Abedi, Kirsten Grunnet, Ib Jarle Christensen et al. · Frontiers in Oncology · 2021 · 30 citations · Full text

Rows per page

1–5 of 7